Extension study 5 and 10 years visit

Observational extension study 5 and 10 years after entering the NORD-STAR trial

Long-term follow-up of a multicenter, randomized, open-label, blinded-assessor, phase 4 study in patients with early rheumatoid arthritis to compare active conventional therapy versus three biologic treatments, and two de-escalation strategies in patients who respond to treatment.